Last updated: April 6, 2023
Sponsor: Mohamed Sayed Abdelhafez
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
N/AClinical Study ID
NCT02673359
WR2
Ages 20-35 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women with singleton pregnancy.
- History of preterm labor and/or midtrimester miscarriage in a previous pregnancy.
- Cervical length of 15-25 mm by transvaginal sonography (TVS) at 16-24 weeks ofgestation.
Exclusion
Exclusion Criteria:
- Age < 20 or > 35 years.
- Congenital uterine malformation.
- Multifetal pregnancy.
- Known major fetal structural or chromosomal abnormality.
- Known allergy or contraindication (relative or absolute) to progesterone therapy.
- Presence of contraindication to cervical cerclage.
- Medical conditions complicating pregnancy.
- Vaginal bleeding.
Study Design
Total Participants: 220
Study Start date:
February 01, 2016
Estimated Completion Date:
January 31, 2024
Study Description
Connect with a study center
Private practice settings
Mansoura, Dakahlia
EgyptSite Not Available
Obstetrics and Gynecology Department in Mansoura University Hospital
Mansourah, Dakahlia 35111
EgyptActive - Recruiting
Private practice settings
Mansourah, Dakahlia
EgyptActive - Recruiting
Obstetrics and Gynecology Department in Port Said University
Port Said,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.